Neuroscience
Ketamine
100%
Glutamic Acid
93%
Bipolar Disorder
85%
Antidepressant
72%
Anterior Cingulate Cortex
63%
Placebo
55%
Nuclear Magnetic Resonance Spectroscopy
55%
Treatment of Depression
42%
Meta-Analysis
42%
Receptor
36%
Mood Disorder
32%
μ-Opioid Receptor
31%
Endorphin
31%
Kappa Opiate Receptor
31%
Delta Opiate Receptor
31%
Depressive Disorder
29%
Synaptic Transmission
28%
Neuroplasticity
24%
Neurogenesis
24%
Drug Therapy
24%
Brain-Derived Neurotrophic Factor
22%
Clinical Psychiatry
21%
Working Memory
21%
Psychotomimetic
21%
Bipolar Depression
21%
MDMA
21%
Posttraumatic Stress Disorder
21%
Brain Imaging
21%
Zinc Transporter
21%
Diazepam
21%
Hypothalamic-Pituitary-Adrenal Axis
21%
Treatment-Resistant Depression
13%
Beck Depression Inventory
10%
Hippocampus
9%
Major Depressive Disorder
8%
Psilocybin
8%
Brain Areas
8%
Bipolar II Disorder
8%
Magnetic Resonance Imaging
8%
Mental Disorder
8%
Glutamine
8%
Randomized Controlled Trial
7%
Neuroscience
7%
Oxidative Stress
7%
Pharmacology, Toxicology and Pharmaceutical Science
Ketamine
71%
Psychotomimetic
63%
Major Depression
46%
Placebo
41%
Antidepressant
37%
Psilocybin
29%
Mood Disorder
23%
Anxiety Disorder
23%
Opiate Receptor
22%
Treatment Resistant Depression
22%
Drug Screening
21%
Narcotic Antagonist
21%
MDMA
21%
Posttraumatic Stress Disorder
21%
Bipolar Depression
21%
ICD-10
17%
Randomized Controlled Trial
16%
Diseases
11%
Side Effect
10%
Depressive Disorder
8%
Remission
8%
Nausea
7%
Clinical Trial
7%
Pharmacodynamics
7%
Tolerability
7%
Pharmacokinetic
7%
Medicine and Dentistry
Ketamine
31%
Major Depressive Episode
21%
Psilocybine
21%
Single Drug Dose
21%
Brain Imaging
21%
Glutamic Acid
21%
Treatment of Depression
21%
Montgomery-Åsberg Depression Rating Scale
17%
Antidepressant
14%
Antidepressant Activity
14%
Treatment Resistant Depression
13%
Brain Region
10%
Clinical Trial
10%
Endorphin
10%
κ-Opioid Receptor
10%
Opioid Receptor
10%
Delta Opiate Receptor
10%
Kappa Opiate Receptor
10%
μ-Opioid Receptor
10%
Therapy Effect
10%
Adverse Effect
6%